* Meta-terms correspond to biological or medical specialty concerned
with one or more keywords (or keywords hierarchies), qualifiers, or resource types.
Other terms also benefit from this structure, when the topic warrants it, eg education.
See the list.
Preferred Label : risk management;
True Meta (CISMeF) : O;
Origin ID : MT111;
MeSH
Validated automatic mappings to BTNT
https://www.srlf.org/media/interview-silvia-calvino-gestion-securite-catheters-centraux-reanimation
2025
France
video recording
safety management
interviews as topic
resuscitation
catheters
catheterization, central venous
---
https://ansm.sante.fr/tableau-marr/isatuximab
2025
false
false
false
France
French
risk management
isatuximab
guideline
patient education handout
blood transfusion
indirect coombs test
Laboratory test interference
---
https://www.cochrane.org/fr/CD013745/CENTRALED_quels-sont-les-benefices-et-risques-des-anticoagulants-oraux-directs-aod-les-anticoagulants-de
2025
United Kingdom
review of literature
french abstract
Transcatheter Aortic Valve Replacement
anticoagulant, nos
leadership
aortic valve
risk assessment
replacement of catheter
guideline
risks and benefits
generations
anticoagulants
aorta, nos
oral anticoagulants
family characteristics
---
https://www.cochrane.org/fr/CD016168/CENTRALED_quels-sont-les-benefices-et-risques-des-transfusions-de-sang-et-de-produits-sanguins-pour-la-prise
2025
United Kingdom
review of literature
french abstract
blood
risk assessment
blood transfusion
postpartum hemorrhage
risks and benefits
hemorrhage
transfusion, nos
postpartum hemorrhage, nos
blood specimen collection
patient care management
risk-taking
---
https://ansm.sante.fr/actualites/medicaments-a-base-de-methotrexate-par-voie-orale-imeth-novatrex-et-generiques-une-carte-patients-et-une-brochure-professionnels-de-sante-pour-eviter-les-surdosages
2025
false
false
false
France
French
risk management
risk
methotrexate
poisoning
pharmacovigilance note
guideline
patients guideline
---
https://www.cochrane.org/fr/CD015083/CENTRALED_quels-sont-les-benefices-et-risques-des-modeles-alternatifs-de-prestation-de-soins-pour-les
2025
United Kingdom
review of literature
french abstract
lumbago
nursing
low back pain
delivery of health care
risk assessment
persons
proportional hazards models
hazards models
risks and benefits
---
https://www.inspq.qc.ca/publications/3622
2025
Canada
technical report
risk factors
cold, nos
risk management
risk factor
coldness
health communication
risk
cold temperature
hazardous substances
persons
---
https://ansm.sante.fr/actualites/contraception-et-risque-de-meningiome-nouvelles-recommandations
2025
false
false
false
France
French
risk management
contraceptives, oral, hormonal
meningioma
patients guideline
guidelines for drug use
continuity of patient care
risk
desogestrel
risk factors
meningioma
---
https://www.cochrane.org/fr/CD013429/CENTRALED_quels-sont-les-benefices-et-les-risques-de-la-dilatation-de-la-trompe-deustache-par-ballonnet-pour
2025
United Kingdom
review of literature
french abstract
risk assessment
risks and benefits
dysfunction of eustachian tube
dilatation, nos
eustachian tube
dilatation
obstruction of eustachian tube, nos
---
https://www.has-sante.fr/jcms/p_3598771/fr/tuberculose-pulmonaire-structurer-le-depistage-et-le-reperage-precoce-dans-les-populations-a-risque
2025
France
scientific and technical information
early medical intervention
tuberculosis, pulmonary
risk assessment
tuberculosis
communication
population at risk
mass media
press releases
communism
respiratory tuberculosis
risk factors
screening
early diagnosis
---
https://www.inrs.fr/media.html?refINRS=QR+186
2025
France
journal article
lifting
transportation
accidents, occupational
accident site
carrying
occupational diseases
workplace
work-related activity accident, nos
disease
accident while engaged in work-related activity, nos
disease, nos
---
https://ansm.sante.fr/tableau-marr/sel-de-fer-injectable
2025
false
false
false
France
French
risk management
iron compounds
iron, parenteral preparations
patient education handout
guidelines for drug use
injections, intravenous
infusions, intravenous
iron compounds
anaphylaxis
drug hypersensitivity
Drug-Related side effects and adverse reactions
---
https://www.reiso.org/articles/themes/pratiques/13516-la-securite-motivation-des-marcheur-ses-benevoles
2025
Switzerland
journal article
popular works
motivation, nos
safety
volunteers
motivation
decreased motivation
---
https://ansm.sante.fr/tableau-marr/mavacamten
2025
false
false
false
France
French
risk management
mavacamten
mavacamten
mavacamten
administration, oral
patients guideline
guidelines for drug use
fetus
pregnancy
embryo
drug interactions
heart failure, systolic
Fetal exposure to drug (situation)
Cytochrome P-450 CYP2C19 Inhibitors
Cytochrome P-450 CYP3A4 Inhibitors
Cytochrome P450 family 2 subfamily C member 19 intermediate metabolizer (finding)
Cytochrome P450 family 2 subfamily C member 19 ultra-rapid metabolizer (finding)
Cytochrome P450 family 2 subfamily C member 19 poor metabolizer (finding)
Cytochrome P450 family 2 subfamily C member 19 normal metabolizer (finding)
patient education handout
---
https://ansm.sante.fr/tableau-marr/zilucoplan
2025
false
false
false
France
French
risk management
guidelines for drug use
patients guideline
injections, subcutaneous
zilucoplan
Drug-Related side effects and adverse reactions
zilucoplan
complement inactivating agents
vaccination
meningococcal infections
meningococcal vaccines
guideline
---
https://ansm.sante.fr/tableau-marr/lomitapide
2025
false
false
false
France
French
risk management
lomitapide
lomitapide
patient education handout
guideline
drug interactions
anticholesteremic agents
lomitapide
anticholesteremic agents
administration, oral
---
https://ansm.sante.fr/tableau-marr/eliglustat
2025
false
false
false
France
French
risk management
eliglustat
guidelines for drug use
drug interactions
popular works
eliglustat
gaucher disease, type 1
Cytochrome P-450 CYP2D6 Inhibitors
P-glycoprotein Inhibitor
Genotyping
continuity of patient care
Metabolic Side Effects of Drugs and Substances
---
https://ansm.sante.fr/tableau-marr/lisocabtagene-maraleucel
2025
false
false
false
France
French
guidelines for drug use
risk management
Lisocabtagene Maraleucel
Lisocabtagene Maraleucel
Product containing only lisocabtagene maraleucel in parenteral dose form (medicinal
product form)
Cytokine Release Syndrome
continuity of patient care
gene therapy
immunotherapy, adoptive
signs and symptoms
nervous system diseases
patients guideline
lisocabtagene maraleucel
---
https://ansm.sante.fr/tableau-marr/eladocagene-exuparvovec
2025
false
false
false
France
French
risk management
guidelines for drug use
Eladocagene Exuparvovec
drug compounding
Stereotactic surgery
stereotaxic techniques
gene therapy
Intraputaminal Route of Administration
aromatic amino acid decarboxylase deficiency
Injection of brain (procedure)
infusions, parenteral
neurosurgical procedures
patient education handout
guideline
eladocagene exuparvovec
---
https://ansm.sante.fr/tableau-marr/idecabtagene-vicleucel
2025
false
false
false
France
French
guidelines for drug use
popular works
risk management
idecabtagene vicleucel
idecabtagene vicleucel
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
drug compounding
idecabtagene vicleucel
gene therapy
immunotherapy, adoptive
idecabtagene vicleucel
continuity of patient care
nervous system diseases
infusions, intravenous
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
multiple myeloma
Cytokine Release Syndrome
Cytokine Release Syndrome
signs and symptoms
defrosting
---
https://ansm.sante.fr/tableau-marr/adrenaline
2025
false
false
false
France
French
risk management
guidelines for drug use
epinephrine
epinephrine
Self injection
self administration
patient education handout
video recording
---
https://ansm.sante.fr/tableau-marr/lauromacrogol-400
2025
false
false
false
France
French
risk management
guidelines for drug use
Polidocanol
polidocanol
patients guideline
Polidocanol
Drug-Related side effects and adverse reactions
continuity of patient care
Polidocanol
drug compounding
---
https://ansm.sante.fr/tableau-marr/rivaroxaban
2025
false
false
false
France
French
Rivaroxaban
risk management
guidelines for drug use
continuity of patient care
administration, oral
medication errors
hemorrhage
Drug-Related side effects and adverse reactions
Rivaroxaban
package leaflet
video recording
---
https://ansm.sante.fr/tableau-marr/cladribine
2025
false
false
false
France
French
risk management
cladribine
administration, oral
cladribine
immunosuppressive agents
cladribine
guidelines for drug use
patients guideline
Drug-Related side effects and adverse reactions
adult
multiple sclerosis, relapsing-remitting
continuity of patient care
hematologic tests
---
https://ansm.sante.fr/tableau-marr/methoxyflurane
2025
false
false
false
France
French
risk management
methoxyflurane
administration, inhalation
guidelines for drug use
methoxyflurane
methoxyflurane
Drug-Related side effects and adverse reactions
emergency treatment
pain
wounds and injuries
Post-traumatic pain
---
https://ansm.sante.fr/tableau-marr/adrenaline-3
2025
false
false
false
France
French
risk management
epinephrine
guidelines for drug use
self administration
injections, intramuscular
epinephrine
anaphylaxis
patients guideline
drug storage
video recording
epinephrine
---
https://ansm.sante.fr/tableau-marr/levodopa-carbidopa
2025
false
false
false
France
French
risk management
carbidopa
levodopa
drug combinations
carbidopa, levodopa drug combination
Intestinal Route of Administration
patient care
nursing care
patient care planning
guidelines for drug use
patient education handout
continuity of patient care
patient care management
---
https://ansm.sante.fr/tableau-marr/icodextrine
2025
false
false
false
France
French
risk management
guidelines for drug use
peritoneal dialysis
blood glucose self-monitoring
Icodextrin
Blood glucose meter (physical object)
directory
patient education handout
---
https://ansm.sante.fr/tableau-marr/clozapine
2025
false
false
false
France
French
clozapine
risk management
patient education handout
blood cell count
forms
agranulocytosis
continuity of patient care
drug monitoring
---
https://ansm.sante.fr/tableau-marr/lutecium-177lu-oxodotreotide
2025
false
false
false
France
French
lutetium Lu 177 dotatate
risk management
patients guideline
lutetium Lu 177 dotatate
infusions, intravenous
radiotherapy
radiopharmaceuticals
radiopharmaceuticals
neuroendocrine tumors
lutetium (177Lu) oxodotreotide
drug information
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide
---
https://ansm.sante.fr/tableau-marr/pomalidomide
2025
false
false
false
France
French
risk management
pregnancy
contraception
teratogens
abnormalities, drug-induced
multiple myeloma
pomalidomide
continuity of patient care
Drug-Related side effects and adverse reactions
risk factors
guidelines for drug use
thrombocytopenia
neutropenia
blood cell count
thromboembolism
Infections
patient education handout
pregnancy tests
forms
thalidomide
thalidomide
---
https://www.inrs.fr/media.html?refINRS=TC+182
2025
France
journal article
work
occupation, nos
risk
---
https://www.inrs.fr/media.html?refINRS=TF+324
2025
France
journal article
data collection
men
risk
dissent and disputes
jurisprudence
---
https://www.inrs.fr/media.html?refINRS=TM+83
2025
France
journal article
demography
health
safety
due to
population growth
demographers
---
https://ansm.sante.fr/tableau-marr/etranacogene-dezaparvovec
2025
false
false
false
France
French
risk management
Etranacogene Dezaparvovec
etranacogene dezaparvovec
guidelines for drug use
patients guideline
popular works
thromboembolism
Drug-Related side effects and adverse reactions
Chemical and Drug Induced Liver Injury
gene therapy
Gene Therapy Agents
semen
blood
DNA-Mediated Gene Transfer
pregnancy
gene transfer, horizontal
---
https://orbi.uliege.be/handle/2268/330020
2025
Belgium
journal article
pediatrician
risk
pediatrics
---
https://www.inrs.fr/media.html?refINRS=TC%20182
2025
France
journal article
work
occupation, nos
risk
---
Fluenz - influenza vaccine (live attenuated, nasal)
https://www.ema.europa.eu/en/medicines/human/EPAR/fluenz
2025
false
false
false
France
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
influenza, human
influenza vaccines
vaccination
Trivalent Live-Attenuated Influenza Vaccine
---
https://drees.solidarites-sante.gouv.fr/publications-communique-de-presse/etudes-et-resultats/250403_ER_patients-soins-critiques-covid-19-risques
2025
France
journal article
patient care
risk
mechanical ventilation, nos
has patient
COVID-19
death
critical care
respiration, artificial
ventilation, mechanical
vulnerable populations
Disadvantaged Populations
---
https://www.academie-medecine.fr/de-lorigine-du-sars-cov-2-aux-risques-de-zoonoses-et-de-manipulations-dangereuses-de-virus/
2025
France
technical report
manipulation
viruses
zoonoses
zoonosis, nos
virus, nos
risk
Handling, Psychological
SARS-CoV-2
---
https://www.cochrane.org/fr/CD006027/CENTRALED_quels-sont-les-benefices-et-risques-des-anti-inflammatoires-non-steroidiens-ains-pour-le-traitement
2025
United Kingdom
review of literature
french abstract
non-steroidal anti-inflammatory agent, nos
renal colic
risk assessment
colic
kidney, nos
risks and benefits
anti-inflammatory agents, non-steroidal
abdominal colic
---
https://www.cochrane.org/fr/CD015127/CENTRALED_securite-et-utilite-des-inhibiteurs-de-la-pompe-protons-chez-les-nourrissons-prematures-atteints-de
2025
United Kingdom
review of literature
french abstract
disease
proton
infant
pump, nos
infant, premature, diseases
proton pump inhibitors
reflux, nos
disease, nos
safety
proton-pump inhibitors
immature
---
https://www.has-sante.fr/jcms/p_3600306/fr/fluenz-vaccin-grippal-trivalent-vivant-attenue-nasal-vaccin-antigrippal
2025
France
evaluation of the transparency committee
influenza vaccines
vaccination
vaccines, attenuated
preventive immunization/medication
attenuated by
nose, nos
influenza virus vaccine
---
https://www.academie-medecine.fr/accidents-graves-dus-aux-collisions-entre-skieurs/
2025
France
scientific and technical information
accidents
accidents, traffic
collision
accident, nos
---
https://www.has-sante.fr/jcms/p_3598581/fr/flash-securite-patient-erreurs-diagnostiques-dans-les-services-des-urgences-diagnostic-manque-urgence-aggravee
2025
France
scientific and technical information
patient safety
emergency service, hospital
no diagnosis
Missed Diagnosis
emergencies
has patient
diagnostic services
---
https://www.has-sante.fr/jcms/p_3599791/fr/label-flash-securite-patient-neuroleptiques-a-action-prolongee-nap-les-nap-parfois-ca-derape
2025
France
guideline
professional practice
tool, nos
antipsychotic agents
has patient
patient safety
id
long
---
https://beh.santepubliquefrance.fr/beh/2025/7/2025_7_2.html
2025
France
journal article
risk
hot temperature
medical futility
athletic performance
heat
heat, nos
---
https://www.afmps.be/fr/news/les_medicaments_de_therapie_innovante_non_reglementes_presentent_de_graves_risques_pour_la
2025
false
false
false
Belgium
French
innovative therapies
risk
patient safety
pharmacovigilance note
Dendritic Cell Therapy
immunotherapy, adoptive
dendritic cells
legislation, drug
europe
belgium
---
https://www.has-sante.fr/jcms/p_3574072/fr/transition-du-vaccin-antigrippal-fluenz-de-sa-forme-quadrivalente-a-une-forme-trivalente-dans-la-strategie-de-vaccination-contre-la-grippe-saisonniere
2025
France
public health guidelines
preventive immunization/medication
due to
influenza vaccination
vaccination
health planning guidelines
influenza, human
influenza vaccines
influenza
influenza virus vaccine
vaccination
---
https://www.has-sante.fr/jcms/p_3576102/fr/sam-de-l-ansm-sur-le-valproate-modification-des-conditions-de-prescription-et-de-delivrance-cpd-pour-les-patients-adolescents-et-hommes-afin-de-limiter-les-risques-potentiels-de-troubles-neurodeveloppementaux-pour-les-enfants-a-naitre-lies-a-l-exposition-paternelle-dans-les-trois-mois-precedant-la-conception
2025
France
evaluation of the transparency committee
indexing
medical futility
child
conception
meconium aspiration syndrome
adolescence
patients
macrophage activation syndrome
risk
paternal exposure
prescription, nos
men
adolescent
Neurodevelopmental Disorders
decision support techniques
father, nos
drug design
operations research
drug, nos
valproic acid
valproate
has patient
delivery, obstetric
effects of exposure to external cause, nos
mosaic variegated aneuploidy syndrome
Abstracting and Indexing
child, nos
valproate
---
https://www.has-sante.fr/jcms/p_3576148/fr/sam-de-l-ansm-sur-la-carbamazepine-modification-des-conditions-de-prescription-et-de-delivrance-cpd-pour-les-patientes-afin-de-reduire-les-risques-malformatifs-lies-a-l-exposition-in-utero
2025
France
evaluation of the transparency committee
professional practice
congenital abnormalities
prescription, nos
pharmaceutical preparations
operations research
indexing
macrophage activation syndrome
carbamazepine
risk
tool, nos
Exhibition
decision support techniques
meconium aspiration syndrome
patients
uterus, nos
carbamazepine
has patient
mosaic variegated aneuploidy syndrome
delivery, obstetric
developmental anomaly, nos
drug, nos
effects of exposure to external cause, nos
Abstracting and Indexing
---
https://ansm.sante.fr/tableau-marr/denosumab
2025
false
false
false
France
French
risk management
Denosumab
patient education handout
drug information
osteonecrosis
Osteonecrosis of Jaw
---
https://www.cochrane.org/fr/CD015005/CENTRALED_quels-sont-les-benefices-et-les-risques-de-lazathioprine-un-type-de-medicament-qui-affecte-la
2025
United Kingdom
review of literature
french abstract
organ part
Organisms Category
azathioprine
disease
risks and benefits
organizations
disease, nos
drug, nos
affect, nos
multiple sclerosis
risk assessment
affect
pharmaceutical preparations
immune response, nos
persons
azathioprine
multiple sclerosis, nos
multiple sclerosis
---
https://www.inserm.fr/actualite/maladie-dalzheimer-un-nouvel-algorithme-pour-aider-a-depister-les-personnes-a-risque/
2025
France
evaluation of the transparency committee
persons
alzheimer disease
risk
alzheimer's disease, nos
homemaker services
algorithms
caregivers
---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-interne-clement-boutet
2025
France
audiovisual aids
student, nos
sex
sex ratio
men
france
sexual intercourse, nos
data collection
Pre-Exposure Prophylaxis
hazards models
students
albumin/globulin ratio
proportional hazards models
duration
detective
coitus
french
---
https://www.has-sante.fr/jcms/p_3576094/fr/reprogrammation-au-bloc-operatoire-une-pratique-a-ne-pas-banaliser
2025
France
guideline
solution, nos
operating rooms
systolic pressure
tool, nos
solutions
professional practice
has patient
patient safety
---
https://www.chu-lyon.fr/prophylaxie-pre-exposition-du-vih-prep
2025
France
popular works
human immunodeficiency virus, nos
HIV
prophylactic treatment, nos
Pre-Exposure Prophylaxis
effects of exposure to external cause, nos
---
https://www.cochrane.org/fr/CD012532/CENTRALED_quels-sont-les-benefices-et-les-risques-des-differents-medicaments-dimmunotherapie-pour-traiter-le
2025
United Kingdom
review of literature
french abstract
drug therapy
risk assessment
brain neoplasms
drug, nos
immunotherapy
risks and benefits
immunotherapy, nos
glioblastoma
glioblastoma, nos
---
https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/bpco-et-insuffisance-respiratoire-chronique/documents/rapport-synthese/surveillance-des-maladies-respiratoires-chroniques-chez-les-travailleurs-affilies-au-regime-general.-prevalences-et-secteurs-d-activite-et-professi
2025
France
technical report
dataset
chronic disease
chronic respiratory disease, nos
Chronic Disease Indicators
chronically ill
occupation, nos
risk
diet, nos
respiratory tract diseases
occupations
general practitioners
prevalence
including
---
https://anap.fr/s/article/fiche-transmission-bloc-operatoire-soins
2025
France
scientific and technical information
nursing
insurance
operating rooms
aftercare
---
https://beh.santepubliquefrance.fr/beh/2025/3-4/2025_3-4_2.html
2025
France
journal article
early detection of cancer
cancer of the uterine cervix
screening for cancer
Program
period analysis
organization
french
uterine cervical neoplasms
demography
mass screening
malignant neoplasm cervix
cancer screening
insurance coverage
france
---
https://beh.santepubliquefrance.fr/beh/2025/3-4/2025_3-4_4.html
2025
France
journal article
malignant neoplasm colon/rectum
Respect
france
french
Colorectal Cancer
insurance coverage
colorectal neoplasms
early detection of cancer
screening for cancer
cancer screening
appraiser
---
https://www.hgr-css.be/fr/avis/9782/mesures-de-reduction-des-dommages-et-des-risques-lies-a-la-consommation-dalcool
2025
France
public health guidelines
risk reduction behavior
risk reduction
harm reduction
risk assessment
ethyl alcohol
alcohol drinking
measures
---
https://ansm.sante.fr/tableau-marr/thiocolchicoside
2025
false
false
false
France
French
risk management
thiocolchicoside
patient education handout
guidelines for drug use
thiocolchicoside
fetus
Genotoxicity
administration, oral
injections, intramuscular
pregnancy
breast feeding
Male
female
thiocolchicoside
contraception
---
https://ansm.sante.fr/tableau-marr/pseudoephedrine
2025
false
false
false
France
French
pseudoephedrine
risk management
drug information
patients guideline
nasal decongestants
drug combinations
administration, oral
pseudoephedrine, combinations
common cold
---
https://anavips.fr/
2025
France
association of patients
insurance pools
health
association
---
https://www.academie-medecine.fr/prise-en-charge-des-facteurs-de-risque-cardiovasculaire-des-personnes-agees-de-75-ans-et-plus/
2025
France
technical report
risk-taking
aged
patient care management
age factors
aged, 80 and over
elderly person, nos
Cardiovascular Risk
risk factors
age factor
cardiovascular risk
risk factor
---
https://www.cochrane.org/fr/CD005133/RENAL_le-traitement-preventif-par-antiviraux-contribue-t-il-reduire-le-risque-de-maladie-cytomegalovirus
2025
United Kingdom
review of literature
french abstract
has patient
Diseases Category
cytomegalovirus
risk
antiviral agents
disease
transplant, nos
transplants
patients
disease, nos
cytomegalovirus, nos
preventive treatment, nos
---
https://www.santepubliquefrance.fr/presse/2025/virus-influenza-aviaire-hautement-pathogene-iahp-les-autorites-sanitaires-francaises-poursuivent-leurs-actions-et-renforcent-leur-cooperation-f
2025
France
popular works
relief work
viruses
adaptation, nos
face
habilitation
homo sapiens
influenza A virus
rehabilitation
humans
influenzavirus, nos
risk
influenza in birds
---
https://sante.gouv.fr/IMG/pdf/dgs-urgent_no2025-04_iahp.pdf
2025
France
wakefulness
risk
influenzavirus a
influenza A virus
viruses
Reinforcement, Psychology
homo sapiens
bone screws
reinforcement, nos
humans
simian immunodeficiency virus
wakefulness
---
https://www.anses.fr/fr/content/communique-de-presse-virus-influenza-aviaire-hautement-pathogene-iahp
2025
France
influenza A virus
habilitation
influenza in birds
homo sapiens
adaptation, nos
risk
face
influenzavirus, nos
relief work
viruses
rehabilitation
humans
---
https://www.assurance-maladie.ameli.fr/etudes-et-donnees/par-theme/pathologies/cartographie-assurance-maladie/methode-cartographie-pathologies-depenses-assurance-maladie
2025
France
scientific and technical information
health expenditures
disease
expenditures
insurance, health
protestantism
disease, nos
geographic mapping
---
https://ansm.sante.fr/tableau-marr/ranibizumab-4
2025
false
false
false
France
French
drug information
patient education handout
risk management
Ranibizumab
Drug-Related side effects and adverse reactions
eye diseases
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release
solution for injection (clinical drug)
intravitreal injections
ranibizumab
---
https://ansm.sante.fr/tableau-marr/cerliponase-alfa
2025
false
false
false
France
French
guidelines for drug use
risk management
cerliponase alfa
cerliponase alfa
infusions, intracerebroventricular
Movement of device from original site
Device related infection
Device occlusion
infusions, intracerebroventricular
---
https://ansm.sante.fr/tableau-marr/denosumab-1
2025
false
false
false
France
French
risk management
Denosumab
denosumab
Drug-Related side effects and adverse reactions
patient education handout
drug information
osteonecrosis
jaw diseases
Osteonecrosis of Jaw
---
https://www.has-sante.fr/jcms/p_3589971/fr/sam-de-l-ansm-sur-la-codeine-modification-des-conditions-de-prescription-et-de-delivrance-cpd-afin-de-reduire-le-risque-de-mesusage-d-addiction-et-de-surdosage
2025
false
false
false
France
drug prescriptions
guideline
codeine
substance-related disorders
Drug Misuse
prescription drug misuse
medical order entry systems
algorithms
risk management
codeine
drug overdose
---
https://www.has-sante.fr/jcms/p_3590025/fr/sam-de-l-ansm-sur-le-tramadol-modification-des-conditions-de-prescription-et-de-delivrance-cpd-afin-de-reduire-le-risque-de-mesusage-d-addiction-et-de-surdosage
2025
France
algorithms
operations research
macrophage activation syndrome
indexing
Abstracting and Indexing
mosaic variegated aneuploidy syndrome
drug overdose, nos
behavior, addictive
decision support techniques
delivery, obstetric
risk
prescription, nos
drug overdose
tramadol
dependent drug abuse
---
https://ansm.sante.fr/tableau-marr/tolcapone
2025
false
false
false
France
French
risk management
continuity of patient care
Chemical and Drug Induced Liver Injury
neuroleptic malignant syndrome
Tolcapone
tolcapone
liver function tests
drug information
patient education handout
---
https://ansm.sante.fr/tableau-marr/tremelimumab
2025
false
false
false
France
French
tremelimumab
tremelimumab
risk management
drug information
patient education handout
Immune-Mediated Adverse Reaction
Drug-Related side effects and adverse reactions
signs and symptoms
Drug-Related side effects and adverse reactions
---
https://www.inspq.qc.ca/publications/3615
2025
Canada
public health guidelines
retirement, nos
anesthesia
risk assessment
risk management
retirement
lack of sensation
---
https://www.ofdt.fr/publication/2025/evolution-du-nombre-de-condamnations-pour-infractions-de-securite-routiere-alcool
2025
France
scientific and technical information
french
alcoholics
alcohol, nos
alcohols
ethyl alcohol
safety
alcoholism
france
---
https://www.senat.fr/rap/l24-286/l24-286.html
2025
France
legislation
technical report
law
safety
health personnel
health
---
https://sante.gouv.fr/IMG/pdf/dgs-urgent_no2025-04_reply_iahp.pdf
2025
France
scientific and technical information
homo sapiens
reinforcement, nos
Reinforcement, Psychology
influenzavirus a
wakefulness
wakefulness
bone screws
viruses
risk
simian immunodeficiency virus
influenza A virus
humans
---
https://www.ameli.fr/assure/actualites/le-vapotage-et-le-ptc-chez-les-jeunes-un-phenomene-inquietant-aux-risques-meconnus
2025
France
scientific and technical information
Vaping
worrisome mood
risk
adolescent
---
https://www.bag.admin.ch/bag/fr/home/das-bag/aktuell/news/news-19-02-2025.html
2025
Switzerland
scientific and technical information
safety
---
https://www.academie-medecine.fr/comment-mieux-gerer-les-facteurs-de-risques-cardio-vasculaires-des-personnes-agees/
2025
France
guidelines
aged
aged, 80 and over
risk factor
age factors
cardiovascular system, nos
cardiovascular risk
elderly person, nos
risk factors
age factor
---
https://www.cochrane.org/fr/CD014937/RENAL_quels-sont-les-benefices-et-les-risques-des-diuretiques-pour-prevenir-ou-traiter-latteinte-renale
2025
United Kingdom
review of literature
french abstract
risk assessment
diuretic, nos
risks and benefits
attentiveness
kidney, nos
diuretics
acute kidney injury
---
https://www.cochrane.org/fr/CD016119/CENTRALED_quels-sont-les-benefices-et-les-risques-de-la-myomectomie-pendant-une-cesarienne-chez-les-femmes
2025
United Kingdom
review of literature
french abstract
Myomectomy
leiomyoma
pregnancy, nos
fibromyoma uterus
leiomyoma, nos
Pregnant People
uterine myomectomy
risk assessment
risks and benefits
cesarean section, nos
fibroid uterus
uterine myomectomy, nos
cesarean section
---
https://beh.santepubliquefrance.fr/beh/2025/HS/2025_HS_7.html
2025
France
journal article
risk factors
risk-taking
cardiovascular risk
risk behavior
risk factor
behavior, nos
Cardiovascular Risk
epidemiologic factors
---
https://beh.santepubliquefrance.fr/beh/2025/HS/2025_HS_8.html
2025
France
journal article
cardiovascular risk
risk behavior
epidemiologic factors
risk factor
Cardiovascular Risk
behavior, nos
risk factors
risk-taking
---
https://minerva-ebp.be/FR/Article/2423
2025
Belgium
critical appraisal or critical reading
cardiovascular risk
has patient
case histories
diabetes mellitus
systolic pressure
stroke/cerebrovascular accident
patients
Cardiovascular Risk
stroke
due to
cerebrovascular accident, nos
systolic arterial pulse pressure, nos
Embolic Stroke
risk
blood pressure, nos
blood pressure
---
https://www.cochrane.org/fr/CD013614/CENTRALED_quels-sont-les-benefices-et-risques-des-inhibiteurs-du-tnf-chez-les-personnes-atteintes-de
2025
United Kingdom
review of literature
french abstract
psoriasis, nos
arthritis
disease
risk assessment
polyarthritis
Polyarthritis
psoriasis
risks and benefits
tumor necrosis factor
persons
Tumor Necrosis Factor Inhibitors
anti-TNF
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1425
2025
France
public health guidelines
hazardous substances
pesticides
emigration and immigration
humans
drinking
homo sapiens
risk management
pesticide, nos
water consumption
---
https://publications.msss.gouv.qc.ca/msss/document-003857/
2025
Canada
technical report
accidents
health services
social work
research report
incidence
quebec
socialism
albumin/globulin ratio
delivery of health care
accident, nos
---
https://www.cochrane.org/fr/CD013715/CENTRALED_quels-sont-les-benefices-et-les-risques-des-inhibiteurs-du-facteur-de-necrose-tumorale-pour
2025
United Kingdom
review of literature
french abstract
rheumatoid arthritis, systemic juvenile
risk factors
arthritis, nos
unknown (origin)
risk factor
arthritis, juvenile
Tumor Necrosis Factor Inhibitors
risk assessment
risks and benefits
tumor necrosis factor
---
https://ansm.sante.fr/tableau-marr/selexipag
2024
false
false
false
France
French
risk management
Uptravi
medication errors
selexipag
patients guideline
guidelines for drug use
Wrong dose
selexipag
---
https://ansm.sante.fr/tableau-marr/olipudase-alfa
2024
false
false
false
France
French
guidelines for drug use
popular works
risk management
olipudase alfa
olipudase alfa
Drug-Related side effects and adverse reactions
infusions, intravenous
home infusion therapy
Infusion-Related Reaction
drug hypersensitivity
anaphylaxis
olipudase alfa
---
https://ansm.sante.fr/tableau-marr/cemiplimab
2024
false
false
false
France
French
risk management
patients guideline
cemiplimab
Antineoplastic Agents, Immunological
infusions, intravenous
cemiplimab
drug monitoring
lymphohistiocytosis, hemophagocytic
drug information
lymphohistiocytosis, hemophagocytic
---
https://ansm.sante.fr/tableau-marr/axicabtagene-ciloleucel
2024
false
false
false
France
French
risk management
axicabtagene ciloleucel
guidelines for drug use
axicabtagene ciloleucel
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
nervous system diseases
patient education handout
signs and symptoms
axicabtagene ciloleucel
infusions, intravenous
gene therapy
---
https://ansm.sante.fr/tableau-marr/brexucabtagene-autoleucel
2024
false
false
false
France
French
risk management
brexucabtagene autoleucel
genetic therapy
gene therapy
Cytokine Release Syndrome
signs and symptoms
guidelines for drug use
patient education handout
Drug-Related side effects and adverse reactions
nervous system diseases
brexucabtagene autoleucel
brexucabtagene autoleucel
---
https://ansm.sante.fr/tableau-marr/venetoclax
2024
false
false
false
France
French
risk management
venetoclax
venetoclax
patient education handout
tumor lysis syndrome
administration, oral
antineoplastic agents
---
https://ansm.sante.fr/tableau-marr/panobinostat
2024
false
false
false
France
French
risk management
Panobinostat
panobinostat
administration, oral
medication errors
patients guideline
patient compliance
---
https://ansm.sante.fr/tableau-marr/tacrolimus
2024
false
false
false
France
French
risk management
tacrolimus
tacrolimus
administration, oral
guidelines for drug use
patient education handout
continuity of patient care
immunosuppressive agents
---
https://ansm.sante.fr/tableau-acces-derogatoire/oxbryta-voxelotor
2024
false
false
false
France
French
risk management
voxelotor
voxelotor
administration, oral
hematologic agents
drug information
anemia, hemolytic
anemia, sickle cell
Safety-Based drug withdrawals
---
https://ansm.sante.fr/tableau-marr/inebilizumab
2024
false
false
false
France
French
risk management
inebilizumab
inebilizumab
infusions, intravenous
patients guideline
product surveillance, postmarketing
patient safety
adult
neuromyelitis optica
Immunosuppression-related infectious disease (disorder)
leukoencephalopathy, progressive multifocal
virus diseases
serious infection
---
https://ansm.sante.fr/tableau-marr/leflunomide
2024
false
false
false
France
French
risk management
patients guideline
guidelines for drug use
Leflunomide
leflunomide
administration, oral
immunosuppressive agents
continuity of patient care
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/ponesimod
2024
false
false
false
France
French
risk management
ponesimod
ponesimod
administration, oral
ponesimod
ponvory
guidelines for drug use
patients guideline
pregnancy
continuity of patient care
ponesimod
adult
multiple sclerosis, relapsing-remitting
drug monitoring
immunosuppressive agents
immunosuppressive agents
immunosuppressive agents
---
https://ansm.sante.fr/tableau-marr/nalmefene
2024
false
false
false
France
French
risk management
nalmefene
nalmefene
guidelines for drug use
patient education handout
administration, oral
patient compliance
patients guideline
alcohol drinking
continuity of patient care
nalmefene
alcoholism
adult
algorithms
Psychosocial Intervention
---
https://ansm.sante.fr/tableau-marr/onasemnogene-abeparvovec
2024
false
false
false
France
French
guidelines for drug use
risk management
Zolgensma
onasemnogene abeparvovec
infusions, intravenous
patients guideline
child
spinal muscular atrophies of childhood
onasemnogene abeparvovec-xioi
biological products
recombinant fusion proteins
---
https://ansm.sante.fr/tableau-marr/eculizumab
2024
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
drug monitoring
patient safety
sepsis
meningococcal infections
risk
vaccination
antibiotic prophylaxis
adult
child
infant
patients guideline
patient education handout
Drug-Related side effects and adverse reactions
meningococcal vaccines
---
https://ansm.sante.fr/tableau-marr/etonogestrel
2024
false
false
false
France
French
risk management
guidelines for drug use
patients guideline
patient education handout
etonogestrel
drug implants
Insertion of etonogestrel radiopaque contraceptive implant (procedure)
Removal of etonogestrel radiopaque contraceptive implant (procedure)
Insertion of subcutaneous contraceptive in arm (procedure)
etonogestrel
contraceptive agents, female
progestins
---
https://ansm.sante.fr/tableau-marr/tolvaptan
2024
false
false
false
France
French
risk management
Tolvaptan
Tolvaptan
administration, oral
tolvaptan
polycystic kidney, autosomal dominant
continuity of patient care
liver diseases
pregnancy
guidelines for drug use
patients guideline
patient education handout
---
https://ansm.sante.fr/tableau-marr/olanzapine
2024
false
false
false
France
French
guidelines for drug use
patient education handout
Olanzapine
risk management
olanzapine
injections, intramuscular
Delayed-Action preparations
Olanzapine
metabolic diseases
continuity of patient care
drug compounding
injections, intramuscular
olanzapine pamoate
olanzapine pamoate
schizophrenia
antipsychotic agents
antipsychotic agents
medication errors
Post-injection delirium sedation syndrome (finding)
---
https://www.cancer.fr/catalogue-des-publications/agir-pour-sa-sante-contre-les-risques-de-cancer2
2024
false
false
false
France
Healthy Lifestyle
neoplasms
patient education handout
risk
health
Cancer
neoplasms
risk
cancer
hazardous substances
health
neoplasm, malignant
---
https://publications.msss.gouv.qc.ca/msss/document-002140/
2024
false
false
false
Canada
popular works
immunization
quebec
influenza, nos
health
health personnel
Program
Examination Questions
Intertrochanteric fracture
vaccination, nos
immunization programs
intention
influenza, human
immunization
health
---
https://www.conseil-national.medecin.fr/publications/communiques-presse/observatoire-securite-medecins-2023
2024
false
false
false
France
French
technical report
workplace violence
physicians
safety
---
https://ansm.sante.fr/tableau-marr/teriflunomide
2024
false
false
false
France
French
administration, oral
risk reduction
patients guideline
handbooks
pregnancy
teratogens
teriflunomide
risk management
contraception
Contraindications, Drug
breast feeding
Chemical and Drug Induced Liver Injury
continuity of patient care
multiple sclerosis, relapsing-remitting
leukopenia
hypertension
opportunistic infections
teriflunomide
crotonates
toluidines
crotonates
toluidines
---
https://ansm.sante.fr/tableau-marr/acitretine
2024
false
false
false
France
French
guidelines for drug use
patients guideline
risk management
teratogens
continuity of patient care
acitretin
acitretin
pregnancy
contraception
administration, oral
acitretin
mental disorders
drug monitoring
Chemical and Drug Induced Liver Injury
pancreatitis
psoriasis
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/alitretinoine
2024
false
false
false
France
French
guidelines for drug use
patients guideline
forms
administration, oral
teratogens
pregnancy
contraception
alitretinoin
mental disorders
dyslipidemias
continuity of patient care
pancreatitis
transaminases
Chemical and Drug Induced Liver Injury
drug monitoring
risk management
clinical chemistry tests
patient education handout
Drug-Related side effects and adverse reactions
Alitretinoin
Alitretinoin
---
https://ansm.sante.fr/tableau-marr/atezolizumab
2024
false
false
false
France
French
atezolizumab
atezolizumab
atezolizumab
Drug-Related side effects and adverse reactions
risk management
drug information
patient education handout
Drug-Related side effects and adverse reactions
signs and symptoms
antineoplastic agents
antineoplastic agents
immune system diseases
immune system diseases
antibodies, monoclonal
antibodies, monoclonal
---
https://ansm.sante.fr/tableau-marr/emicizumab
2024
false
false
false
France
French
emicizumab
risk management
thromboembolism
hemorrhage
thrombotic microangiopathies
blood coagulation tests
risk
hemorrhage
hemophilia A
patients guideline
guidelines for drug use
handbooks
Drug-Related side effects and adverse reactions
injections, subcutaneous
emicizumab
emicizumab
continuity of patient care
antibodies, bispecific
antibodies, monoclonal, humanized
---
https://ansm.sante.fr/tableau-marr/insuline-degludec
2024
false
false
false
France
French
risk management
insulin degludec
medication errors
guidelines for drug use
injections, subcutaneous
insulin degludec
patient education handout
hypoglycemic agents
guideline
insulin, long-acting
---
https://ansm.sante.fr/tableau-marr/insuline-glargine
2024
false
false
false
France
French
Insulin Glargine
medication errors
risk management
insulin glargine
guidelines for drug use
patients guideline
---
https://ansm.sante.fr/tableau-marr/isotretinoine
2024
false
false
false
France
French
administration, oral
isotretinoin
risk management
acne vulgaris
isotretinoin
teratogens
pregnancy
contraception
mental disorders
dyslipidemias
Chemical and Drug Induced Liver Injury
patient education handout
forms
pancreatitis
guidelines for drug use
continuity of patient care
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/lenalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
lenalidomide
multiple myeloma
lymphoma, mantle-cell
teratogens
continuity of patient care
drug monitoring
clinical chemistry tests
myelodysplastic syndromes
guidelines for drug use
popular works
venous thromboembolism
Tumor Flare Reaction
neoplasms
Chemical and Drug Induced Liver Injury
angiogenesis inhibitors
angiogenesis inhibitors
thalidomide
thalidomide
thalidomide
Lenalidomide
Lenalidomide
---
https://ansm.sante.fr/tableau-marr/levonorgestrel-diu
2024
false
false
false
France
French
administration, intravaginal
levonorgestrel
risk management
patient education handout
intrauterine devices, medicated
plastic iud with progestogen
pregnancy, ectopic
risk
guideline
Insertion of intrauterine contraceptive device (procedure)
Contraceptive Effectiveness
---
https://ansm.sante.fr/tableau-marr/pembrolizumab
2024
false
false
false
France
French
risk management
pembrolizumab
Infusion related reaction
immune system diseases
Drug-Related side effects and adverse reactions
patient education handout
pregnancy
continuity of patient care
drug monitoring
Antineoplastic Agents, Immunological
pembrolizumab
antibodies, monoclonal
antibodies, monoclonal, humanized
---
https://ansm.sante.fr/tableau-marr/rituximab
2024
false
false
false
France
French
risk management
Rituximab
Rituximab
infusions, intravenous
injections, subcutaneous
rituximab
risk
leukoencephalopathy, progressive multifocal
Infections
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring
patient education handout
drug compounding
---
https://ansm.sante.fr/tableau-marr/sonidegib
2024
false
false
false
France
French
risk management
sonidegib
teratogens
pregnancy
abnormalities, drug-induced
contraception
pregnancy tests
antineoplastic agents
fetal death
patient education handout
guidelines for drug use
guideline
sonidegib
biphenyl compounds
pyridines
---
https://ansm.sante.fr/tableau-marr/thalidomide
2024
false
false
false
France
French
risk management
thalidomide
teratogens
abnormalities, drug-induced
pregnancy
thalidomide
guideline
forms
patient education handout
continuity of patient care
Neuropathy peripheral
thromboembolism
Drug-Related side effects and adverse reactions
pregnancy tests
contraception
package leaflet
---
https://ansm.sante.fr/tableau-marr/valproate-et-derives
2024
false
false
false
France
French
risk management
valproate
pregnancy
teratogens
valproate sodium
-
Divalproex Sodium
dipropylacetamide
pregnancy tests
contraception
guideline
patient education handout
forms
developmental disabilities
Contraindications, Drug
valproic acid
valproic acid
---
https://ansm.sante.fr/tableau-marr/vandetanib
2024
false
false
false
France
French
risk management
vandetanib
vandetanib
Cardiotoxicity
adult
child
posterior leukoencephalopathy syndrome
death, sudden
long qt syndrome
torsades de pointes
continuity of patient care
drug monitoring
drug interactions
medication errors
vandetanib
handbooks
popular works
RET Gene Mutation
guidelines for drug use
piperidines
quinazolines
piperidines
quinazolines
---
https://www.inrs.fr/media.html?refINRS=TS855page44
2024
France
journal article
Safety
Safety Study
safety
---
https://www.santepubliquefrance.fr/docs/priorisation-des-couples-maladie-facteur-de-risque-pour-l-estimation-du-fardeau-environnemental-et-professionnel-de-la-maladie-en-france
2024
false
false
false
France
technical report
Health Care Professional Promotional Material
Risk Estimate
appraiser
Disease Steps Clinical Classification
france
tularemia
CHFR Gene
family characteristics
risk factors
tularemia, nos
Professional Occupation
environmental illness
risk factor
couples
risk assessment
Couple
Disease Free
Environmental Risk Factor
Disease Object
cost of illness
occupational diseases
hazardous substances
Coupler Device
Burden
No Evidence of Coronary Artery Disease
---
https://ansm.sante.fr/tableau-marr/susoctocog-alfa
2024
false
false
false
France
French
risk management
Susoctocog Alfa
medication errors
guidelines for drug use
drug dosage calculations
video recording
---
https://cps.ca/fr/documents/position/le-jeu-risque-exterieur
2024
Canada
public health guidelines
injury, nos
risk
child development
Child Individual
Injury
Healthy
Development Batch
injuries
Outdoors
Prevention Study
wounds and injuries
child, nos
Preventive Intervention
Outer
play
Balance
Prevention
Child Relation
Development Lot
Balanced Translocation
play and playthings
Maturation
---
https://www.inrs.fr/media.html?refINRS=FO%2040
2024
France
journal article
Preventive Intervention
risk
gait
identified
Prevention Study
Machinery Heart Murmur
gait, nos
Goes Out
machine, nos
Prevention
Usually Need Help from Another Person for Arising
---
https://ansm.sante.fr/tableau-marr/mecasermine
2024
false
false
false
France
French
risk management
mecasermin
mecasermin
mecasermin
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
mecasermin
hypoglycemia
injections, subcutaneous
---
https://www.cancer.fr/catalogue-des-publications/cancers-de-la-peau-s-informer-sur-les-risques-et-se-proteger-brochure
2024
false
false
false
France
patient education handout
Informed
Slice
Informative
Claudin-6
Go Skating
Murine Skin
Oprelvekin
Tiludronate Disodium
Ivermectin
No Information Available
Thaw
skin
Skin
risk
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/depistage-du-diabete-de-type-2-et-evaluation-du-risque-cardiovasculaire.html
2024
Canada
technical report
Cardiovascular Risk
Last Screening
Eligibility Determination
Genetic Screening
Trial Screening
Health Risk Assessment
Murine Cardiovascular System
Type 2 Diabetes Mellitus
Site Screening
Cancer Screening
mass screening
diabetes non-insulin dependent
screening for diabetes
screening
risk assessment
diabetes mellitus, type 2
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Screening Study
Cardiovascular
Cardiovascular System
cardiovascular risk
Substance Screening
---
https://www.louvainmedical.be/fr/article/prevention-primaire-les-cobenefices-pour-la-sante-et-lenvironnement
2024
Belgium
journal article
preventive medicine
Environmental
principal
Approximate
Surrounding
Primary Prevention
primary prevention
environmental health
---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2024-vedolizumab-ustekinumab-anti-tnf-grossesse-mici
2024
France
scientific and technical information
safety
TNF Gene
Ustekinumab
inflammatory bowel disease, nos
tumor necrosis factor
Institutional Review Board Independent Ethics Committee Notification of Safety Information
Documentation
Physically Feel in Bad Condition
tumor necrosis factors
Safety Report
Clinical Trial Notification of Safety or Other Trial Information Documentation
chronic disease, nos
Vedolizumab
research report
vedolizumab
disease
Tumor Necrosis Factor
anti-TNF
Ustekinumab
Chronic Disease
Pregnant People
inflammatory bowel diseases
vedolizumab
pregnancy, nos
albumin/globulin ratio
chronic disease
Gravida
---
https://www.has-sante.fr/jcms/p_3415710/fr/strategie-de-vaccination-contre-la-covid-19-place-du-vaccin-comirnaty-bivalent-original/baba-4-5-10-g/dose-dans-la-strategie-de-rappel-des-enfants-de-5-a-11-ans-revolus-a-risque-de-forme-grave
2024
France
public health guidelines
Vaping
Offspring
Severity Four Out of Five
risk
Recollect
child, nos
severe
health planning guidelines
Eleven
COVID-19 Vaccines
Loss of Chromosome 11
vaccination
Callback
Reminder
Per Hundred Thousand
Bivalent Vaccines
Serious Risk
Recommendation
Strategy
Per Ten Thousand
Vaccination
Child
preventive immunization/medication
child
Vaccine
Placement
vaccination
Booster
vaccinia virus vaccine
Autonomic Nervous System
---
https://www.has-sante.fr/jcms/p_3494049/fr/experimentation-par-la-has-de-la-methode-de-labellisation-d-indicateurs-concus-par-des-organismes-externes-pour-l-amelioration-de-la-qualite-et-de-la-securite-des-soinsa-partir-de-2024
2024
France
technical report
Outer
Organisms Category
quality improvement
organizations
protestantism
nursing
Technique
organ part
Enhance
Test Method
indicators and reagents
Improved
safety
Health Care Organization
Methodology
Quality of Care
Labeled
External Route of Administration
Pars Externa
indication of
Safety Study
Safety
suggestive of
CDISC SDTM Method Terminology
---
https://ansm.sante.fr/tableau-marr/aciclovir
2024
false
false
false
France
French
guideline
patients guideline
drug information
risk management
acyclovir
Accidental Drug Ingestion
Muco-adhesive Buccal Tablet Dosage Form
---
https://ansm.sante.fr/tableau-marr/methotrexate-per-os
2024
false
false
false
France
French
guidelines for drug use
risk management
methotrexate
administration, oral
patient education handout
medication errors
---
https://ansm.sante.fr/tableau-marr/adalimumab
2024
false
false
false
France
French
Adalimumab
risk management
continuity of patient care
drug information
adult
child
patient education handout
---
https://sante.gouv.fr/IMG/pdf/feuille-de-route-medicaments-fevrier-2024.pdf
https://sante.gouv.fr/actualites/presse/communiques-de-presse/article/penuries-de-medicaments-la-ministre-du-travail-de-la-sante-et-des-solidarites
2024
France
technical report
Nutritional Supplement Drink
insurance, pharmaceutical services
industry
GDC Therapeutic Agent Terminology
insurance coverage
Date Available
Availability
drug insurance
drug, nos
drug industry
Long-Term
Pharmacologic Substance
---
https://www.cochrane.org/fr/CD013789/MUSKINJ_les-interventions-basees-sur-la-population-celles-qui-visent-des-communautes-entieres-plutot-que-des
2024
United Kingdom
review of literature
french abstract
attentiveness
Injury
Quite a Bit
injuries
aged
Population Intervention
aged, 80 and over
accidental falls
population
injury, nos
persons
Elderly
residence characteristics
community
elderly person, nos
wounds and injuries
What Month is it
---
https://www.cochrane.org/fr/CD015432/SYMPT_quels-sont-les-benefices-et-les-risques-de-libuprofene-dans-la-prise-en-charge-de-la-douleur-apres
2024
United Kingdom
review of literature
french abstract
pain
child, nos
Pain Therapy
During or After
Status Post
ibuprofen
pain management
risks and benefits
Surgical Procedure
pain, nos
operative procedure, nos
child
What Month is it
Child Relation
surgical procedures, operative
Ibuprofen
risk-taking
risk assessment
Operation
ibuprofen
Child Individual
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1368
2024
France
public health guidelines
Ventilation
Neither Agree or Disagree
administration, topical
Theophylline
Localized Disease
hygiene
Location of Oral Residue Following Swallowing
attentiveness
Location of Pharyngeal Residue Following Swallowing
risk
Relative Value
judgment
Local-Regional
Anatomic Site
ventilation
Usage
epidemics
ventilation, nos
Locally
with cleaniless
Epidemic Disorder
Usually Need Help from Another Person for Hygiene
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1369
2024
France
guideline
Neither Agree or Disagree
usutu virus
Virus
simian immunodeficiency virus
homo sapiens
risk
judgment
humans
Disease Transmission
Usutu virus
bone screws
Supplies
Usutu virus
Human Origin
---
https://www.has-sante.fr/jcms/p_3497216/fr/labellisation-par-la-has-d-un-flash-securite-patient-elabore-par-un-organisme-externe
2024
France
guideline
Scientific Equipment
outpatients
Professional Practice
organ part
tool, nos
professional practice
Outpatient
Safety
organizations
Improved
CASP8AP2 wt Allele
Whole Organism
patient safety
Tool
Enhance
Organism Part
societies
has patient
Labeled
Safety Study
---
https://iris.who.int/handle/10665/376078
2024
Switzerland
technical report
Paraneoplastic Syndrome is Not Present
communicable disease control
Caffeine Not Routinely Consumed
Has No Sibling
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Chief Complaint Not Caused by Trauma
Local Anesthesia Agents were not Administered
health personnel
Radiation History Negative
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Physician Diagnosed Diabetes Absent
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Additional Surgery for New Tumor Event Absent
principal
Chemical/Occupational Exposure Absent
EGFR Gene Amplification Negative
EGFR Amplification Analysis Was Not Performed
Cancer History Absent
Preoperative IV Antiemetics were not Administered
New Tumor Event After Initial Treatment Absent
Minor Criteria for Rheumatic Heart Disease Not Present
Therapeutic Ionizing Radiation to Head History Absent
Optimization
PTEN Gene Mutation Negative
Adjuvant Post-operative Radiation Therapy Was Not Administered
PDGFRA Mutation Analysis Was Not Performed
Routine Cytogenetics Were not Completed
10q23/PTEN Locus Deletion Analysis Was Not Performed
Adjuvant Post-operative Immunological Therapy Was Not Administered
Not Lost to Follow-Up
NON Mouse
Another Form of Birth Control was not Used
No History of Congenital Heart Disease
ATRX Gene Mutation Negative
Improved
Medication Not Taken
First Degree Family History of Primary Brain Tumor Negative
No History of Non-Cardiac Surgery
Preoperative IV Sedation was Not Administered
First Degree Family History Thyroid Cancer Negative
Regional Anesthesia was not Administered
Any Metastatic Diagnosis Absent
delivery of health care
1p/19q Deletion Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
BRAF Mutation Analysis Was Not Performed
Negation
Neither Case or Control Status
kenya
Chemotherapy Not Received
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Health Care Delivery
Noncommunicable Diseases
EGFR Mutation Analysis Was Not Performed
Tumor Reoccurrence Absent After Initial Treatment
No History of Myopathy
Delegate Action
First Degree Family History Cancer Negative
PTEN Mutation Analysis Was Not Performed
Enhance
health services
Additional Immunohistochemistry Was Not Performed
KRAS Mutation Analysis Was Not Performed
health benefits
Chief Complaint was Not Witnessed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Primary Care
Unemployed
Lymph Node Dissection Was Not Performed
History of Medical Treatment Absent
SDH Complex Mutation Analysis Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
IDH Family Wildtype
Radiation Therapy Not Received
IV Anesthesia was not Administered
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
No History of Kawasaki Disease
No History of Neonatal Complication
Norway
No Response to Intervention for Kawasaki Disease
ALK Rearrangement Analysis Was Not Performed
Other Preoperative IV Medications were not Administered
New Disease is not Multifocal
Preoperative IV Opiates were not Administered
No Known History of Alcohol Use
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Tumor Progression Absent After Initial Treatment
RET Rearrangement Analysis Was Not Performed
Share
Documentation Absent
Shared
primary health care
State or Local Health Department
Additional Molecular Studies Were Not Performed
NRAS Mutation Analysis Was Not Performed
insurance benefits
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Adjuvant I-131 Therapy Negative
MET Mutation Analysis Was Not Performed
Research Personnel
BRAF Rearrangement Analysis Was Not Performed
Evidence of Disease Absent after Completion of Therapy
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Preoperative IV Antacids were not Administered
No Known History of Illicit Drug Use
MGMT Promoter Methylation Testing Was Not Performed
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New
Tumor Event
ERBB2 Mutation Analysis Was Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Hypertension Absent
On Staff
Care Of
No History of Rheumatic Fever
History of Colorectal Cancer Negative
NF1 Mutation Analysis Was Not Performed
Nitric Oxide
No History of Gestational Complication
TP53 Mutation Analysis Was Not Performed
personnel delegation
KIT Mutation Analysis Was Not Performed
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
communicable disease, nos
ATRX Mutation Analysis Was Not Performed
Nitric Oxide Measurement
Use of Smokeless Tobacco at Time of Diagnosis Negative
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Intervention Not Given for Kawasaki Disease
primary health care
IDH Family Mutation Analysis Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
Fluorescence In Situ Hybridization Was Not Performed
Patient was Not Previously Evaluated for Current Chief Complaint
Communicable Disorder
Patient was not Postmenopausal with no Prior Oophorectomy
Family History of Stomach Cancer Absent
Neither
Adjuvant Post-operative Chemotherapy Was Not Administered
---
https://www.has-sante.fr/jcms/p_3499384/fr/labellisation-par-la-has-d-un-flash-securite-patient-elabore-par-un-organisme-externe
2024
France
evaluation of the transparency committee
Handbook
methods
Safety Study
Organisms Category
PRETEXT Stage 4
patient safety
has patient
PRETEXT Stage 3
PRETEXT Stage 1
organ part
Safety
PRETEXT Stage 2
organizations
outpatients
Whole Organism
Organism Part
CASP8AP2 wt Allele
Guide Device
Outpatient
Labeled
---
https://ansm.sante.fr/tableau-marr/tocilizumab-1
2024
false
false
false
France
French
risk management
tocilizumab
infusions, intravenous
injections, subcutaneous
guidelines for drug use
tocilizumab
tocilizumab
patient education handout
continuity of patient care
tocilizumab
---
https://ansm.sante.fr/tableau-marr/sarilumab
2024
false
false
false
France
French
risk management
continuity of patient care
drug information
injections, subcutaneous
antibodies, monoclonal, humanized
sarilumab
patients guideline
---
https://publications.msss.gouv.qc.ca/msss/document-003698/
2024
Canada
scientific and technical information
algorithms
genets
genetics
gene, nos
Clinical Trial Eligibility Criteria
mars
Genetic Testing
Handbook
insurance
Interpretation
genetta, nos
cytisus
interpreter
Department
March
Software Service
Guide Device
viverridae
Algorithm
---
https://www.anses.fr/fr/system/files/BIORISK2021SA0019Ra.pdf
https://www.anses.fr/fr/system/files/BIORISK2021SA0019Ra-Anx-13.pdf
2024
France
technical report
cost savings
protestantism
Adverse Event Definitely Related to Intervention
judgment
Some
bays
albumin/globulin ratio
genomics
Genome
Economics
Medium Growth Rate
Approximate
risk
CDISC SDTM Protocol Risk Assessment Response Codelist
Device Evaluation Method
Relative Risk
Evaluation Method
economics
relative risk
Obtain
A Medium Amount of Time
environment
Growth Medium
Media
socioeconomic factors
health risk appraisal
hazardous substances
Medium Heart Murmur
evaluation report
plant, nos
Moderately Bothered
plants
Technique
Environmental
Health Risk Assessment
Certain
Hazard Ratio
genome
evaluation studies as topic
Plant
genome, plant
Neither Agree or Disagree
Middle Lobe of the Prostate
genome, nos
Middle
Surrounding
inlets
health status indicators
---
https://www.has-sante.fr/jcms/p_3500291/fr/flash-securite-patient-patient-tracheotomise-en-service-de-soins-critiques-tracheo-quand-la-vie-ne-tient-qu-a-un-tuyau
2024
France
scientific and technical information
has patient
Life
trachea, nos
Safety
patient safety
Vietnamese Language
Laser-Induced Fluorescence Endoscopy
Hose Device
critical care
CASP8AP2 wt Allele
life
Safety Study
Care Of
VIE Regimen
Pipe
patient care
Patient Care
Pipe Dosing Unit
---
https://www.inrs.fr/media.html?refINRS=QR%20179
2024
France
journal article
What Month is it
viruses
risk
influenza a virus, h5n1 subtype
charadriiformes
Disease Transmission
Influenza A (H5N1) Virus
Contamination during Use
virus, nos
gull, nos
---
https://www.inrs.fr/media.html?refINRS=TM%2078
2024
France
journal article
Safety
occupational health
Safety Study
safety
Occupational Health
occupation, nos
---
https://ansm.sante.fr/tableau-marr/tafamidis
2024
false
false
false
France
French
risk management
tafamidis
administration, oral
guidelines for drug use
tafamidis
adult
pregnancy
breast feeding
tafamidis
Cardiac Amyloidosis
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, hereditary, Transthyretin-Related
---
https://www.cochrane.org/fr/CD012608/LIVER_la-modification-de-lapport-en-graisses-alimentaires-est-elle-benefique-ou-risquee-pour-les-personnes
2024
United Kingdom
review of literature
french abstract
Dietary Route of Administration
gallstones
Modification
Alteration
Cholelithiasis
dietary fats
What Month is it
risk
Amendment
grease, nos
Amendment Regulatory Submission
biliary calculus, nos
persons
Data Change Date
Bile Duct Stone
People
---
https://www.cochrane.org/fr/CD014687/NEUROMUSC_quels-sont-les-benefices-et-les-risques-des-traitements-non-chirurgicaux-et-chirurgicaux-du-nevrome
2024
United Kingdom
review of literature
french abstract
Non-Surgical
Usually Need Help from Another Person for Walking
Hard to Walk More Than One Block
Walking
Morton Neuroma
Morton Neuroma
Symptoms Interfered with Walking
pain, nos
walking
gait, nos
risk assessment
Forward
Raw
morton's metatarsalgia
Treatment Benefit
risks and benefits
What Month is it
ball of foot
Foot Pain
pain
---
https://minerva-ebp.be/FR/Analysis/857
2024
Belgium
critical appraisal or critical reading
Effect, Appearance
Parkinson's Disease Pathway KEGG
Preventive Intervention
parkinson's disease, nos
Outcome of Therapy
What Month is it
parkinson disease
persons
accidental falls
No Effect
Parkinson Disease
People
disease
---
https://dares.travail-emploi.gouv.fr/publication/comment-les-employeurs-previennent-ils-les-risques-professionnels
2024
France
journal article
risk
What Month is it
Employer
---
https://www.inrs.fr/media.html?refINRS=AC%20184
2024
France
journal article
Exhibition
neoplasm, malignant
cancer
Cancer Risk
Exposure Domain
europe
risk factor
Survey
risk factors
risk factor for malignancy
Exposure
Inquiry
neoplasms
occupational neoplasms
effects of exposure to external cause, nos
data collection
No Risk Factors
detective
Occupational Malignant Neoplasm
Investigation
occupational exposure
---
https://www.inrs.fr/media.html?refINRS=QR%20181
2024
France
journal article
Involvement
risk
Hepatitis C Virus Positive
disease
hepatitis, nos
Fix
What Month is it
Disease Transmission
hepatitis
Hepatitis
---
https://www.inrs.fr/media.html?refINRS=TF%20315
2024
France
journal article
Gene Amplification Positive
Tiredness Visual Analogue Scale
Sector
Alcohol Use Disorder Identification Test Self-Report Version Questionnaire
Audit Object
fatigue
Enhancer
Amplifier Device
audition, nos
Fatigue
Hearing
risk
Auditory
Bothered by Tiredness
Audit
Fatigue Subordinate Domain
hearing
amplifiers, electronic
ear, nos
music
EGFR Gene Amplification
auditory fatigue
---
https://iris.who.int/bitstream/handle/10665/376333/WHO-WHE-EPP-2024.3-fre.pdf
2024
Switzerland
public health guidelines
Montreal Cognitive Assessment Orientation Test
Biological Son
Biological or Textual Reference to Actual Test or Parameter
CDISC ADAS-Cog - Orientation Summary Score
orientation
biology
Clinical Trial Notification of Safety or Other Trial Information Documentation
Referral
Biological
Biological Challenge Agent
SARS Coronavirus
laboratory reporting, nos
Biology
biology
Institutional Review Board Independent Ethics Committee Notification of Safety Information
Documentation
SARS-CoV-2
safety
containment of biohazards
Direction
Orientation
Referring
Safety Report
laboratories
COVID-19 Infection
Biological Agent
orientation, nos
research report
COVID-19
---
https://www.has-sante.fr/jcms/p_3502633/fr/flash-securite-patient-transport-intrahospitalier-des-patients-de-soins-critiques-le-transport-lui-aussi-est-critique
2024
France
guideline
tool, nos
professional practice
transportation of patients
Patient Navigation
Safety
Improved
Tool
Professional Practice
Safety Study
patient transfer
evaluation studies as topic
Enhance
CASP8AP2 wt Allele
carrying
patient safety
Veterinary Patient
patient care
has patient
Scientific Equipment
critical care
---
https://publications.msss.gouv.qc.ca/msss/document-003705/
2024
Canada
technical report
incidence
accident, nos
research report
Health Care Delivery
albumin/globulin ratio
quebec
social work
delivery of health care
Social Health Service
socialism
accidents
Care Of
Occurrence
Regulatory Report
health services
Ratio
---
https://minerva-ebp.be/FR/Article/2370
2024
Belgium
critical appraisal or critical reading
knee prosthesis
Smartphone Application
supervision
Limburgish Language
Surgical Procedure was Curative Therapy
residence characteristics
Smartphone
Knee Joint
What Month is it
attention
rehabilitation
Efficacy Study
operative procedure, nos
prosthesis, nos
general surgery
domicile
Safety Issue Application
Surgical Procedure
Shawnee
safety
Management
efficiency
Prosthesis Device Component
Overdenture
---
https://www.cochrane.org/fr/CD014544/CF_quels-sont-les-benefices-et-les-risques-des-nouveaux-traitements-par-facteurs-non-coagulants-pour-la
2024
United Kingdom
review of literature
french abstract
risk factors
blood coagulation factors
hemophilia B
bloodletting
coagulants
Treatment Benefit
Feeding
Breeding
Risk Factor
Coagulation Factor
hemophilia b, nos
persons
risks and benefits
risk factor
F9 wt Allele
Feeding Ability
Prevention Study
Hemophilia B
What Month is it
disease
Raw
coagulation factor, nos
Hemorrhage
Preventive Intervention
risk assessment
bleeding precautions
hemorrhage
People
New Lesion Identification
Newar Language
preventive treatment, nos
---
https://www.cochrane.org/fr/CD015014/COLOCA_quels-sont-les-benefices-et-les-risques-de-loperation-roux-en-y-non-coupee-apres-ablation-de-la
2024
United Kingdom
review of literature
french abstract
risk assessment
Murine Stomach
NT5E wt Allele
neoplasm, malignant
Non-Surgical
Stomach
excision, nos
stomach, nos
malignant neoplasm stomach
stomach neoplasms
Raw
Cancer Therapeutic Procedure
operative procedure, nos
risks and benefits
stomach
Entity Name Data Type
cancer of stomach
surgical procedures, operative
Beyond
What Month is it
Post-Therapy
Ablation Therapy
---
https://www.academie-medecine.fr/les-punaises-de-lit-en-2024-realites-risques-et-impostures/
2024
France
scientific and technical information
risk
bedbugs
Bed
Buginese Language
cimex lectularius
Lithuanian Language
---
https://www.assurance-maladie.ameli.fr/etudes-et-donnees/depenses-risque-statistique-mensuelle
2024
France
scientific and technical information
expenditures
GDC Type Terminology
health expenditures
DUSP4 wt Allele
risk
---
https://www.cochrane.org/fr/CD003331/VASC_quels-sont-les-benefices-et-les-risques-de-la-readaptation-cardiaque-basee-sur-lexercice-pour
2024
United Kingdom
review of literature
french abstract
Cardiac Rehabilitation
risks and benefits
Heart Failure
exercise
heart failure, nos
What Month is it
risk assessment
post-cardiac rehabilitation training
Before Exercise
Exercise
Exercise Pain Management
Cardiac Rehabilitation
heart failure
---
https://ansm.sante.fr/tableau-marr/belatacept
2024
false
false
false
France
French
guidelines for drug use
risk management
BELATACEPT
immunosuppressive agents
infusions, intravenous
belatacept
patient education handout
Infusion-Related Reaction
infusions, intravenous
---
https://ansm.sante.fr/tableau-marr/sutimlimab
2024
false
false
false
France
French
risk management
sutimlimab
guidelines for drug use
sutimlimab
antibodies, monoclonal, humanized
infusions, intravenous
Infections
Infections
meningococcal vaccines
meningococcal infections
vaccination
serious infection
patient education handout
---
https://ansm.sante.fr/tableau-marr/pirfenidone
2024
false
false
false
France
French
guidelines for drug use
risk management
pirfenidone
pirfenidone
administration, oral
patient education handout
photosensitization
Drug-induced photosensitivity (disorder)
pirfenidone
Chemical and Drug Induced Liver Injury
continuity of patient care
liver function tests
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/eculizumab-2
2024
false
false
false
France
French
risk management
eculizumab
eculizumab
eculizumab
guidelines for drug use
patient education handout
patients guideline
antibiotic prophylaxis
infusions, intravenous
Infections
sepsis
Drug-Related side effects and adverse reactions
meningococcal infections
vaccination
meningococcal vaccines
---
https://ansm.sante.fr/tableau-marr/epoprostenol
2024
false
false
false
France
French
patients guideline
risk management
Infection of intravenous catheter (disorder)
Infection of intravenous catheter (disorder)
central venous catheters
epoprostenol
drug information
---
https://www.has-sante.fr/jcms/p_3483264/fr/fluenz-tetra-vaccin-grippal-quadrivalent-vivant-attenue-nasal-vaccin-antigrippal
2024
false
false
false
France
evaluation of the transparency committee
Trivalent Live-Attenuated Influenza Vaccine
preventive immunization/medication
Nasal Route of Administration
Trial Element Duration
Influenza Vaccine
influenza virus vaccine
vaccines, attenuated
Quadrivalent Influenza Vaccine
Nasal Dosage Form
vaccination
nose, nos
influenza vaccines
Tea Leaf
Ezatiostat Hydrochloride
attenuated by
---
https://ansm.sante.fr/tableau-marr/inotersen
2024
false
false
false
France
French
risk management
Inotersen
inotersen
Drug-Related side effects and adverse reactions
patients guideline
drug information
eye diseases
glomerulonephritis
thrombocytopenia
oligonucleotides
oligodeoxyribonucleotides, antisense
---
https://ansm.sante.fr/tableau-marr/etanercept-1
2024
false
false
false
France
French
risk management
Etanercept
patients guideline
drug information
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/eculizumab-1
2024
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
Drug-Related side effects and adverse reactions
vaccination
patients guideline
Infections
sepsis
meningococcal infections
risk
---
https://ansm.sante.fr/tableau-marr/dabigatran
2024
false
false
false
France
French
guidelines for drug use
risk management
Dabigatran
Dabigatran
dabigatran etexilate
administration, oral
antithrombins
antithrombins
continuity of patient care
hemorrhage
risk
adult
child
---
https://ansm.sante.fr/tableau-marr/rituximab-3
2024
false
false
false
France
French
guidelines for drug use
patient education handout
Rituximab
Rituximab
risk management
continuity of patient care
child
infusions, intravenous
leukoencephalopathy, progressive multifocal
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/ravulizumab
2024
false
false
false
France
French
risk management
ravulizumab
ravulizumab
ravulizumab
infusions, intravenous
guidelines for drug use
patients guideline
continuity of patient care
meningococcal infections
sepsis
neisseria meningitidis
vaccination
antibiotic prophylaxis
meningococcal infections
sepsis
child
infant
hemoglobinuria, paroxysmal
Atypical Hemolytic Uremic Syndrome
myasthenia gravis, generalized
---
https://ansm.sante.fr/tableau-marr/dexamethasone
2024
false
false
false
France
French
patient education handout
risk management
dexamethasone
intravitreal injections
---
https://www.anses.fr/fr/content/chlord%C3%A9cone-aux-antilles-les-risques-li%C3%A9s-%C3%A0-l%E2%80%99exposition-alimentaire
2024
false
false
false
France
popular works
chlordecone
risk
chlordecone
Dietary Exposure
effects of exposure to external cause, nos
west indies
---
https://ansm.sante.fr/tableau-marr/fosphenytoine-sodique
2024
false
false
false
France
French
risk management
fosphenytoin
fosphenytoin sodium
guidelines for drug use
child
adult
injections, intramuscular
infusions, intravenous
anticonvulsants
fosphenytoin
medication errors
emergency treatment
status epilepticus
---
https://ansm.sante.fr/tableau-marr/tetradecyl-sulfate-de-sodium
2024
false
false
false
France
French
risk management
guidelines for drug use
continuity of patient care
sodium tetradecyl sulfate
sclerosing solutions
sodium tetradecyl sulfate
sodium tetradecyl sulfate
injections, intravenous
sclerotherapy
drug prescriptions
---
https://ansm.sante.fr/tableau-marr/teclistamab
2024
false
false
false
France
French
popular works
drug information
Teclistamab
risk management
teclistamab
---
https://ansm.sante.fr/tableau-marr/glucagon
2024
false
false
false
France
French
guidelines for drug use
risk management
glucagon
glucagon
administration, intranasal
patient education handout
---
https://www.has-sante.fr/jcms/p_3240311/fr/flash-securite-patient
2024
France
guideline
Improved
Safety
patient safety
Professional Practice
tool, nos
Veterinary Patient
professional practice
occupational health
has patient
Enhance
Tool
Scientific Equipment
CASP8AP2 wt Allele
Safety Study
---
https://www.has-sante.fr/jcms/p_3502487/fr/flash-securite-patient-canicule-personnes-hospitalisees-et-hebergees-en-etablissement-medico-social-mettez-les-patients-au-frais-avant-qu-ils-n-en-fassent-les-frais
2024
France
guideline
strawberry
Recovered from Adverse Event
Inpatient Encounter
Healthcare Facility
Blackberry
Strawberry Flavor
Enhance
Safety Study
CASP8AP2 wt Allele
has patient
Tool
patient safety
tool, nos
residential facilities
Professional Practice
Institution
extreme heat
Strawberry
housing
Blackberry Flavor
professional practice
inpatients
fees and charges
socialism
persons
Improved
charges
Safety
Scientific Equipment
Social
hospital admission, nos
Inpatient
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1374
2024
France
public health guidelines
risk-taking
Catenin Delta-1
hemorrhagic fever, crimean
Coronavirus Anxiety Scale
CTNND1 wt Allele
Case
judgment
Congo-Crimean Hemorrhagic Fever
No Cases Transmission Pattern
relative risk
simian immunodeficiency virus
Prevention
fever
Human
True Case Status
Neither Agree or Disagree
Case Dosing Unit
Relative Risk
Prevention Study
bone screws
congo-crimean hemorrhagic fever
Charge
homo sapiens
BCAR1 wt Allele
risk
Preventive Intervention
snacks
humans
Breast Cancer Anti-Estrogen Resistance Protein 1
patient care management
Packaging Case
---